Cited by 342

The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.

Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential

Open access

Shankar, Sharmila·2007·Frontiers in Bioscience

Open this paper in CoChat — free account

Abstract

Resveratrol, a polyphenol found in numerous plant species, including mulberries, peanuts and grapes, has shown to possess chemopreventive properties against several cancers, and cardiovascular diseases. Recently, resveratrol has been shown to have positive effects on age longevity, lipid levels and a preventative quality against certain cancers and viral infections. Resveratrol induces apoptosis by up-regulating the expression of Bax, Bak, PUMA, Noxa, Bim, p53, TRAIL, TRAIL-R1/DR4 and TRAIL-R2/DR5 and simultaneously down-regulating the expression of Bcl-2, Bcl-XL, Mcl-1 and survivin. Resveratrol causes growth arrest at G1 and G1/S phases of cell cycle by inducing the expression of CDK inhibitors p21/WAF1/CIP1 and p27/KIP1. Resveratrol has also been shown to reduce inflammation via inhibition of prostaglandin production, cyclooxygenase-2 activity, and nuclear factor-kappaB activity. Modulation of cell signaling pathway by resveratrol explains its diverse bioactivities related with human health. Resveratrol also potentiates the apoptotic effects of cytokines, chemotherapeutic agents and gamma-radiation. Pharmacokinetic and pharmacodynamic studies demonstrated that the main target organs of resveratrol are liver and kidney, and it is metabolized by hydroxylation, glucuronidation, sulfation and hydrogenation. As a chemoprevention agent, resveratrol has been shown to inhibit tumor initiation, promotion, and progression. There is growing evidence that resveratrol can prevent or delay the onset of various cancers, heart diseases, ischemic and chemically induced injuries, pathological inflammation and viral infections. This review summarizes the molecular mechanisms of resveratrol and its clinical benefits for human diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2741/2432

Cites

178 of 178 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 2×
“In other studies a inhibition effect of resveratrol on carcinogenesis at multiple stages particularly on skin has been reported (11).”
Background
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Regulation of Cell Death Protease Caspase-9 by Phosphorylation
Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., & Reed, J. C. (1998) · Science · doi:10.1126/science.282.5392.1318 · Cited by 2,481
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase
Nidai Ozes, O., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., & Donner, D. B. (1999) · Nature · doi:10.1038/43466 · Cited by 1,832
Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
Peso, L. D., González-Garcı́a, M., Page, C., Herrera, R., & Nuñez, G. (1997) · Science · doi:10.1126/science.278.5338.687 · Cited by 1,797
The Receptor for the Cytotoxic Ligand TRAIL
Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., & Dixit, V. M. (1997) · Science · doi:10.1126/science.276.5309.111 · Cited by 1,767
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors
Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., et al. (1997) · Science · doi:10.1126/science.277.5327.818 · Cited by 1,664
Biological effects of resveratrol
Frémont, L. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00410-5 · Cited by 1,663
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Mitochondrial control of apoptosis
Kroemer, G., Zamzami, N., & Susin, S. A. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80014-x · Cited by 1,471
The Bcl-2 family: roles in cell survival and oncogenesis
Cory, S., Huang, D. C. S., & Adams, J. M. (2003) · Oncogene · doi:10.1038/sj.onc.1207102 · Cited by 1,463
Oxidative stress and apoptosis
Kannan, K., & Jain, S. K. (2000) · Pathophysiology · doi:10.1016/s0928-4680(00)00053-5 · Cited by 1,284
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
Apoptotic Pathways
Green, D. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81728-6 · Cited by 1,196
The Multiple Roles of PTEN in Tumor Suppression
Di Cristofano, A., & Pandolfi, P. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80674-1 · Cited by 1,182
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL
Walczak, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5386 · Cited by 1,130
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.
Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordán, J., Bellacosa, A., Tsichlis, P. N., & Hay, N. (1997) · Genes & Development · doi:10.1101/gad.11.6.701 · Cited by 1,074
Bcl-2 family proteins
Reed, J. C. (1998) · Oncogene · doi:10.1038/sj.onc.1202591 · Cited by 1,049
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Inhibition of human LDL oxidation by resveratrol
Frankel, E. N., Waterhouse, A. L., & Kinsella, J. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)92472-6 · Cited by 887
Molecular alterations of the AKT 2 oncogene in ovarian and breast carcinomas
Bellacosa, A., De Feo, D., Godwin, A. K., Bell, D. W., Cheng, J. Q., Altomare, D. A., Wan, M., Dubeau, L., Scambia, G., Masciullo, V., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640412 · Cited by 837
The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain
Degli-Esposti, M. A., Dougall, W. C., Smolak, P. J., Waugh, J. Y., Smith, C. A., & Goodwin, R. G. (1997) · Immunity · doi:10.1016/s1074-7613(00)80399-4 · Cited by 821
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803
Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells
Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., & Dannenberg, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21875 · Cited by 786
Bcl-2 Gene Family and the Regulation of Programmed Cell Death
Yin, X.-M., Oltvai, Z. N., Veis-Novack, D. J., Linette, G. P., & Korsmeyer, S. J. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.043 · Cited by 723
Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
Cairns, P., Okami, K., Halachmi, S., Halachmi, N., Esteller, M., Herman, J. G., Jen, J., Isaacs, W. B., Bova, G. S., & Sidransky, D. (1997) · PubMed · Cited by 700
Absorption of three wine-related polyphenols in three different matrices by healthy subjects
Goldberg, D. M., Yan, J., & Soleas, G. J. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00397-1 · Cited by 683
Metabolism and bioavailability oftrans-resveratrol
Wenzel, E., & Somoza, V. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500010 · Cited by 676
Programmed cell death: alive and well in the new millennium
Kaufmann, S. H., & Hengartner, M. O. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02173-0 · Cited by 673
Intracellular Regulation of TRAIL-Induced Apoptosis in Human Melanoma Cells
Griffith, T. S., Chin, W. A., Jackson, G. C., Lynch, D. H., & Kubin, M. Z. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2833 · Cited by 664
14-3-3 Proteins and Survival Kinases Cooperate to Inactivate BAD by BH3 Domain Phosphorylation
Datta, S. R., Katsov, A., Hu, L. S., Petros, A. M., Fesik, S. W., Yaffe, M. B., & Greenberg, M. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00006-x · Cited by 663
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.
Gillett, C., Fantl, V., Smith, D., Fisher, C., Bartek, J. J., Dickson, C., Barnes, D. M., & Peters, G. (1994) · PubMed · Cited by 661
Bcl-2-family proteins: the role of the BH3 domain in apoptosis
Kelekar, A., & Thompson, C. B. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01321-x · Cited by 653
A novel receptor for Apo2L/TRAIL contains a truncated death domain
Marsters, S. A., Sheridan, J. P., Pitti, R. M., Huang, A., Skubatch, M., Baldwin, D., Yuan, J., Gurney, A., Goddard, A. D., Godowski, P., et al. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00422-2 · Cited by 653
TRAIL receptor-2 signals apoptosis through FADD and caspase-8
Bodmer, J.-L., Holler, N., Reynard, S., Vinciguerra, P., Schneider, P., Juo, P., Blenis, J., & Tschopp, J. (2000) · Nature Cell Biology · doi:10.1038/35008667 · Cited by 649
Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family
Degli-Esposti, M. A., Smolak, P. J., Walczak, H., Waugh, J., Huang, C.-P., DuBose, R. F., Goodwin, R. G., & Smith, C. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1165 · Cited by 629
PTEN: a tumour suppressor that functions as a phospholipid phosphatase
Maehama, T. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01519-6 · Cited by 590
NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.
Baeuerle, P. A., & Baichwal, V. R. (1997) · PubMed · Cited by 580
Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
Keane, M., Ettenberg, S. A., Nau, M. M., RUSSELL, E. K., & Lipkowitz, S. (1999) · PubMed · Cited by 551
Biological Effects of Resveratrol
Bhat, K. P. L., Kosmeder, J. W., & Pezzuto, J. M. (2001) · Antioxidants & Redox Signaling · doi:10.1089/152308601317203567 · Cited by 507
Resveratrol as an anticancer nutrient: molecular basis, open questions and promises
Signorelli, P., & Ghidoni, R. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.01.017 · Cited by 489
Molecular cloning and characterisation of a novel putative protein‐serine kinase related to the cAMP‐dependent and protein kinase C families
COFFER, P. J., & WOODGETT, J. R. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16305.x · Cited by 487
Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
Guldberg, P., Straten, P. T., Birck, A., Ahrenkiel, V., Kirkin, A. F., & Zeuthen, J. (1997) · PubMed · Cited by 480
Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase
Holmes-McNary, M. Q., & Baldwin, A. S. (2000) · PubMed · doi:10.17615/wdcc-wb89 · Cited by 444
Naturally Occurring NF-κB Inhibitors
Nam, N.-H. (2006) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955706777934937 · Cited by 436
Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways
Suliman, A., Lam, A., Datta, R., & Srivastava, R. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204282 · Cited by 419
Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats
Su, H.-C., Hung, L.-M., & Chen, J.-K. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00487.2005 · Cited by 412
Cancer Chemopreventive Activity of Resveratrol
BHAT, K. P. L., & PEZZUTO, J. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02918.x · Cited by 398
Solution Structure of the Proapoptotic Molecule BID
McDonnell, J. M., Fushman, D., Milliman, C. L., Korsmeyer, S. J., & Cowburn, D. (1999) · Cell · doi:10.1016/s0092-8674(00)80573-5 · Cited by 396
Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB–regulated antiapoptotic and cell survival gene products in human multiple myeloma cells
Bhardwaj, A., Sethi, G., Vadhan-Raj, Bueso-Ramos, C., Takada, Y., Gaur, U., Nair, A. S., Shishodia, S., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-02-003988 · Cited by 395
NF-κB and cell-cycle regulation: the cyclin connection
JOYCE, D., ALBANESE, C., STEER, J., FU, M., BOUZAHZAH, B., & PESTELL, R. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00018-6 · Cited by 393
Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase.
She, Q., Bode, A. M., Ma, W., Chen, N. Y., & Dong, Z. (2001) · PubMed · Cited by 393
Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?
Kopp, P. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380619 · Cited by 392
The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1
Potter, G. A., Patterson, L. H., Wanogho, E., Perry, P. J., Butler, P. C., Ijaz, T., Ruparelia, K. C., Lamb, J. H., Farmer, P. B., Stanley, L. A., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600197 · Cited by 380
Increased AKT Activity Contributes to Prostate Cancer Progression by Dramatically Accelerating Prostate Tumor Growth and Diminishing p27Kip1 Expression
Graff, J. R., Konicek, B. W., McNulty, A. M., Wang, Z., Houck, K., Allen, S., Paul, J. D., Hbaiu, A., Goode, R. G., Sandusky, G. E., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003145200 · Cited by 378
The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation*
Pestell, R. G., Albanese, C., Reutens, A. T., Segall, J. E., Lee, R. J., & Arnold, A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0373 · Cited by 375
Phytoestrogens: Recent Developments
(2003) · Planta Medica · doi:10.1055/s-2003-41122 · Cited by 339
Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
Huang, C. (1999) · Carcinogenesis · doi:10.1093/carcin/20.2.237 · Cited by 338
Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis
Srivastava, R. K., Mi, Q.-S., Hardwick, J. M., & Longo, D. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3775 · Cited by 336
Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes
Brâkenhielm, E., Cao, R., & Cao, Y. (2001) · The FASEB Journal · doi:10.1096/fj.01-0028fje · Cited by 334
Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells
Matsumura, I. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1367 · Cited by 332
Influence of Induced Reactive Oxygen Species in p53-Mediated Cell Fate Decisions
Macip, S., Igarashi, M., Berggren, P., Yu, J., Lee, S. W., & Aaronson, S. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8576-8585.2003 · Cited by 331
The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance
Mayo, M. W., & Baldwin, A. S. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00002-0 · Cited by 324
Resveratrol Isolated from Polygonum cuspidatum Root Prevents Tumor Growth and Metastasis to Lung and Tumor-Induced Neovascularization in Lewis Lung Carcinoma-Bearing Mice
Kimura, Y., & Okuda, H. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.6.1844 · Cited by 313
Akt is more than just a Bad kinase
Khwaja, A. (1999) · Nature · doi:10.1038/43354 · Cited by 299
Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling
Kops, G. J. P. L., & Burgering, B. M. T. (1999) · Journal of Molecular Medicine · doi:10.1007/s001099900050 · Cited by 283
Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein
Kotha, A., Sekharam, M., Cilenti, L., Siddiquee, K., Khaled, A., Zervos, A. S., Carter, B., Turkson, J., & Jove, R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0268 · Cited by 283
Survival Factor-Mediated BAD Phosphorylation Raises the Mitochondrial Threshold for Apoptosis
Datta, S. R., Ranger, A. M., Lin, M. Z., Sturgill, J. F., Ma, Y.-C., Cowan, C. W., Dikkes, P., Korsmeyer, S. J., & Greenberg, M. E. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00326-x · Cited by 282
Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents
Agarwal, R. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00385-3 · Cited by 280
Cyclin D1 is a candidate oncogene in cutaneous melanoma.
Sauter, E. R., Yeo, U. C., von Stemm, A., Zhu, W., Litwin, S., Tichansky, D. S., Pistritto, G., Nesbit, M., Pinkel, D., Herlyn, M., et al. (2002) · PubMed · Cited by 275
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies
Dahia, P. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.185 · Cited by 274
Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis.
Gansauge, S., Gansauge, F., Ramadani, M., Stobbe, H., Rau, B., Harada, N., & Beger, H. G. (1997) · PubMed · Cited by 261
The Possible Implication of trans-Resveratrol in the Cardioprotective Effects of Long-Term Moderate Wine Consumption
Orallo, F., Álvarez, E., Camiña, M., Leiro, J. M., Gómez, E., & Fernández, P. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12861-1 · Cited by 250
Resveratrol Is Absorbed in the Small Intestine as Resveratrol Glucuronide
Kuhnle, G., Spencer, J. P. E., Chowrimootoo, G., Schroeter, H., Debnam, E. S., Srai, S. K. S., Rice-Evans, C., & Hahn, U. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2750 · Cited by 249
Inhibition of protein kinase B/Akt
Hill, M. M., & Hemmings, B. A. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00193-6 · Cited by 245
Akt-Dependent and -Independent Survival Signaling Pathways Utilized by Insulin-Like Growth Factor I
Kulik, G., & Weber, M. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6711 · Cited by 241
Amplification and Overexpression of Cyclin D1 in Human Hepatocellular Carcinoma
Zhang, Y. J., Jiang, W., Chen, C. J., Lee, C. S., Kahn, S. M., Santella, R. M., & Weinstein, I. B. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2350 · Cited by 241
Effect of trans‐resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function
Rotondo, S., Rajtar, G., Manarini, S., Celardo, A., Rotilio, D., De Gaetano, G., Evangelista, V., & Cerletti, C. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701784 · Cited by 240
Bioactivity and metabolism oftrans-resveratrol orally administered to Wistar rats
Wenzel, E., Soldo, T., Erbersdobler, H., & Somoza, V. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500003 · Cited by 236
Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor α in mice
Inoue, H., Jiang, X.-F., Katayama, T., Osada, S., Umesono, K., & Namura, S. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.001 · Cited by 232
Potential role for Cathepsin D in p53-dependent tumor suppression and chemosensitivity
Wu, G. S., Saftig, P., Peters, C., & El-Deiry, W. S. (1998) · Oncogene · doi:10.1038/sj.onc.1201755 · Cited by 226
Neuroprotection by resveratrol against traumatic brain injury in rats
Ates, O., Cayli, S., Altinoz, E., Gurses, I., Yucel, N., Sener, M., Kocak, A., & Yologlu, S. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9253-0 · Cited by 219
Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats
Tseng, S.-H., Lin, S.-M., Chen, J.-C., Su, Y.-H., Huang, H.-Y., Chen, C.-K., Lin, P.-Y., & Chen, Y. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0105 · Cited by 217
Determination of the prognostic value of cyclin D1 overexpression in breast cancer.
McIntosh, G. G., Anderson, J. J., Milton, I. D., Steward, M., Parr, A., Thomas, M. D., Henry, J. A., Angus, B., Lennard, T. W. J., & Horne, C. H. W. (1995) · PubMed · Cited by 214
Induction of cyclin D1 by simian virus 40 small tumor antigen
Watanabe, G., Howe, A., Lee, R. J., Albanese, C., Shu, I.-W., Karnezis, A. N., Zon, L., Kyriakis, J., Rundell, K., & Pestell, R. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12861 · Cited by 210
Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum.
Gescher, A. J., & Steward, W. P. (2003) · PubMed · Cited by 209
Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF‐alpha
Sharma, S., Chopra, K., & Kulkarni, S. K. (2007) · Phytotherapy Research · doi:10.1002/ptr.2070 · Cited by 208
Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells
Chanvitayapongs, S., Draczynska-Lusiak, B., & Sun, A. Y. (1997) · NeuroReport · doi:10.1097/00001756-199704140-00035 · Cited by 207
Apo2L/TRAIL and Bcl-2–related proteins regulate type I interferon–induced apoptosis in multiple myeloma
Chen, Q., Gong, B., Mahmoud-Ahmed, A. S., Zhou, A., Hsi, E. D., Hussein, M., & Almasan, A. (2001) · Blood · doi:10.1182/blood.v98.7.2183 · Cited by 202
Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
Kandasamy, K., Srinivasula, S. M., Alnemri, E. S., Thompson, C. B., Korsmeyer, S. J., Bryant, J., & Srivastava, R. K. (2003) · PubMed · Cited by 198
PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
Liu, W., James, C. D., Frederick, L. A., Alderete, B. E., & Jenkins, R. B. (1997) · PubMed · Cited by 196
Mitochondrial control of apoptosis: an overview
Kroemer, G. (1999) · Biochemical Society Symposia · doi:10.1042/bss0660001 · Cited by 196
Cell death: TRAIL and its receptors
GOLSTEIN, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)90000-1 · Cited by 194
Mechanisms Involved in Resveratrol‐Induced Apoptosis and Cell Cycle Arrest in Prostate Cancer—Derived Cell Lines
Benitez, D. A., Pozo‐Guisado, E., Alvarez‐Barrientos, A., Fernandez‐Salguero, P. M., & Castellón, E. A. (2007) · Journal of Andrology · doi:10.2164/jandrol.106.000968 · Cited by 186
Inhibitor of Apoptosis Proteins Are Substrates for the Mitochondrial Serine Protease Omi/HtrA2
Srinivasula, S. M., Gupta, S., Datta, P., Zhang, Z., Hegde, R., Cheong, N., Fernandes-Alnemri, T., & Alnemri, E. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300240200 · Cited by 185
Resveratrol, a Polyphenolic Phytoalexin, Attenuates Diabetic Nephropathy in Rats
Sharma, S., Anjaneyulu, M., Kulkarni, S. K., & Chopra, K. (2006) · Pharmacology · doi:10.1159/000089720 · Cited by 177
Bc1-2 protects mice against fatal alphavirus encephalitis.
Levine, B., Goldman, J. E., Jiang, H. H., Griffin, D. E., & Hardwick, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4810 · Cited by 170
Redox regulation of p53 during hypoxia
Chandel, N. S., Vander Heiden, M. G., Thompson, C. B., & Schumacker, P. T. (2000) · Oncogene · doi:10.1038/sj.onc.1203727 · Cited by 167
Inhibition of Cyclin D1 Kinase Activity Is Associated with E2F-Mediated Inhibition of Cyclin D1 Promoter Activity through E2F and Sp1
Watanabe, G., Albanese, C., Lee, R. J., Reutens, A., Vairo, G., Henglein, B., & Pestell, R. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3212 · Cited by 164
Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells
Kim, D. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.871 · Cited by 160
Association between Pterostilbene and Quercetin Inhibits Metastatic Activity of B16 Melanoma
Ferrer, P., Asensi, M., Segarra, R., Ortega, A., Benlloch, M., Obrador, E., Varea, M. T., Asensio, G., Jordá, L., & Estrela, J. M. (2005) · Neoplasia · doi:10.1593/neo.04337 · Cited by 159
Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation
ElAttar, T. M. A., & Virji, A. S. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199902000-00007 · Cited by 157
Resveratrol Induced Serine Phosphorylation Of p53 Causes Apoptosis In A Mutant p53 Prostate Cancer Cell Line
Lin, H., Shih, A., Davis, F. B., Tang, H.-Y., Martino, L. J., Bennett, J. A., & Davis, P. J. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64739-8 · Cited by 157
Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats
Chi, T.-C., Chen, W.-P., Chi, T.-L., Kuo, T., Lee, S., Cheng, J., & Su, M. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.002 · Cited by 156
Interaction of Transresveratrol with Plasma Lipoproteins
Belguendouz, L., Frémont, L., & Gozzelino, M.-T. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00544-3 · Cited by 152
Bcl-2–Mediated Drug Resistance
Srivastava, R. K., Sasaki, C. Y., Hardwick, J. M., & Longo, D. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.253 · Cited by 151
Bcl-2 and Bcl-X L Block Thapsigargin-Induced Nitric Oxide Generation, c-Jun NH 2 -Terminal Kinase Activity, and Apoptosis
Srivastava, R. K., Sollott, S. J., Khan, L., Hansford, R. G., Lakatta, E. G., & Longo, D. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5659 · Cited by 148
Inactivation of thePTEN/MMAC1/TEP1 gene in human lung cancers
Kohno, T., Takahashi, M., Manda, R., & Yokota, J. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199806)22:2<152::aid-gcc10>3.0.co;2-s · Cited by 147
Rel/NF-κB and IκB factors in oncogenesis
Luque, I., & Gélinas, C. (1997) · Seminars in Cancer Biology · doi:10.1006/scbi.1997.0061 · Cited by 142
Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids
Santi, C. D., Pietrabissa, A., Spisni, R., Mosca, F., & Pacifici, G. M. (2000) · Xenobiotica · doi:10.1080/004982500433282 · Cited by 141
Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production
Jang, D.-S., Kang, B.-S., Ryu, S. Y., Chang, I., Min, K. R., & Kim, Y. S. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00350-5 · Cited by 140
Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
Bringuier, P., Tamimi, Y., Schuuring, E. M. D., & Schalken, J. A. (1996) · PubMed · Cited by 139
Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer
Wang, L., Habuchi, T., Takahashi, T., Mitsumori, K., Kamoto, T., Kakehi, Y., Kakinuma, H., Sato, K., Nakamura, A., Ogawa, O., et al. (2002) · Carcinogenesis · doi:10.1093/carcin/23.2.257 · Cited by 137
Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes
Piver, B., Fer, M., Vitrac, X., Mérillon, J., Dréano, Y., Berthou, F., & Lucas, D. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.008 · Cited by 136
Evidence for the stimulatory effect of resveratrol on Ca2+-activated K+ current in vascular endothelial cells
Li, H. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00397-1 · Cited by 133
Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
Kandasamy, K., & Srivastava, R. K. (2002) · PubMed · Cited by 132
Coordinated induction of iNOS–VEGF–KDR–eNOS after resveratrol consumption
Das, S., Alagappan, V. K. T., Bagchi, D., SHARMA, H. S., Maulik, N., & Das, D. K. (2005) · Vascular Pharmacology · doi:10.1016/j.vph.2005.02.013 · Cited by 131
Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma
Bergsagel, P. L., & Kuehl, W. M. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00052.x · Cited by 127
Resveratrol suppresses nuclear factor-κB in herpes simplex virus infected cells
Faith, S. A., Sweet, T. J., Bailey, E., Booth, T. D., & Docherty, J. J. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.06.011 · Cited by 125
Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer
Reissmann, P. T., Koga, H., Figlin, R. A., Holmes, E. C., & Slamon, D. J. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050243 · Cited by 118
Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation
Notas, G., Nifli, A., Kampa, M., Vercauteren, J., Kouroumalis, E., & Castanas, E. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.09.010 · Cited by 117
Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum
Santi, C. D., Pietrabissa, A., Spisni, R., Mosca, F., & Pacifici, G. M. (2000) · Xenobiotica · doi:10.1080/004982500406435 · Cited by 115
Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging
Gautam, S. C., Xu, Y., Dumaguin, M., Janakiraman, N., & Chapman, R. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702189 · Cited by 114
Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.
Mitchell, K. O., & El‐Deiry, W. S. (1999) · PubMed · Cited by 114
Resveratrol inhibition of varicella-zoster virus replication in vitro
Docherty, J. J., Sweet, T. J., Bailey, E. B., Faith, S. A., & Booth, T. D. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.07.004 · Cited by 113
Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells
Shankar, S., Siddiqui, I. A., & Srivastava, R. K. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9510-x · Cited by 112
Self-citation
Apoptosis and cancer chemotherapy
Hickman, J. A., Potten, C. S., Merritt, A. J., & Fisher, T. C. (1994) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1994.0112 · Cited by 111
Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells
Liang, Y., Tsai, S., Chen, L., Lin‐Shiau, S., & Lin, J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00011-x · Cited by 108
Use of Resveratrol to improve the effectiveness of cisplatin and doxorubicin: Study in human gynecologic cancer cell lines and in rodent heart
Rezk, Y. A., Balulad, S. S., Keller, R. S., & Bennett, J. A. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.11.030 · Cited by 105
Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1
Miksits, M., Maier‐Salamon, A., Aust, S., Thalhammer, T., Reznicek, G., Kunert, O., Haslinger, E., Szekeres, T., & Jaeger, W. (2005) · Xenobiotica · doi:10.1080/00498250500354253 · Cited by 101
Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP‐1 signalling pathways
Kim, A. L., Zhu, Y., Zhu, H., Han, L., Kopelovich, L., Bickers, D. R., & Athar, M. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00445.x · Cited by 98
Regioselective and Stereospecific Glucuronidation of trans- and cis-Resveratrol in Human
Aumont, V., Krisa, S., Battaglia, E., Netter, P., Richard, T., Mérillon, J., Magdalou, J., & Sabolovic, N. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2496 · Cited by 97
Reversal of Aging and Chronic Ethanol-induced Cognitive Dysfunction by Quercetin a Bioflavonoid
Singh, A., Naidu, P. S., & Kulkarni, S. K. (2003) · Free Radical Research · doi:10.1080/10715760310001616014 · Cited by 96
The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels
Granados‐Soto, V., Argüelles, C. F., & Ortiz, M. I. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00130-2 · Cited by 93
Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase
Scarlatti, F., Sala, G., Ricci, C., Maioli, C., Milani, F., Minella, M., Botturi, M., & Ghidoni, R. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.01.014 · Cited by 91
Synergistic Inhibition of HIV-1 in Activated and Resting Peripheral Blood Mononuclear Cells, Monocyte-Derived Macrophages, and Selected Drug-Resistant Isolates With Nucleoside Analogues Combined With a Natural Product, Resveratrol
Heredia, A., Davis, C. E. L. B., & Redfield, R. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200011010-00006 · Cited by 91
Cascades of Mammalian Caspase Activation in the YeastSaccharomyces cerevisiae
Kang, J., Schaber, M. D., Srinivasula, S. M., Alnemri, E. S., Litwack, G., Hall, D. J., & Bjornsti, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.3189 · Cited by 90
Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw
Gentilli, M., Mazoit, J. X., Bouaziz, H., et al. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)01018-3 · Cited by 90
Comparison of the antinociceptive effect of celecoxib, diclofenac and resveratrol in the formalin test
Torres‐López, J. E., Ortiz, M. I., Castañeda‐Hernández, G., et al. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01491-1 · Cited by 90
Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro.
Fuggetta, M. P., Lanzilli, G., Tricarico, M., Cottarelli, A., Falchetti, R., Ravagnan, G., & Bonmassar, E. (2006) · PubMed · Cited by 86
Geographical and temporal patterns of incidence and mortality from prostate cancer
Boyle, P., Maisonneuve, P., & Napalkov, P. (1995) · Urology · doi:10.1016/s0090-4295(99)80250-7 · Cited by 86
Resveratrol and the Pharmacology of Aging: A New Vertebrate Model to Validate an Old Molecule
Valenzano, D. R., & Cellerino, A. (2006) · Cell Cycle · doi:10.4161/cc.5.10.2739 · Cited by 85
Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication
Li, Y., Li, Z., Zhao, W.-J., Rui-xing, W., Meng, Q., & Zeng, Y. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.03.024 · Cited by 83
Signalling by proteolysis: death receptors induce apoptosis
Muzio, M. (1998) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990050035 · Cited by 82
Innovative Agents in Cancer Prevention
Manson, M. M., Farmer, P. B., Gescher, A. J., & Steward, W. P. (2005) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/3-540-26980-0_17 · Cited by 82
Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism
Wang, L., Habuchi, T., Mitsumori, K., Li, Z., Kamoto, T., Kinoshita, H., Tsuchiya, N., Sato, K., Οhyama, C., Nakamura, A., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10793 · Cited by 81
Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model
Busquets, S., Ametller, E., Fuster, G., Oliván, M., Raab, V., Argilés, J. M. A., & López-Soriano, F. J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.12.035 · Cited by 81
Glucuronidation of trans -resveratrol by human liver and intestinal microsomes and UGT isoforms
Brill, S., Furimsky, A. M., Ho, M. N., Furniss, M. J., Li, Y., Green, A. G., Green, C. E., Iyer, L., Bradford, W. W., & Kapetanović, I. M. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.4.0006 · Cited by 77
Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism.
Hsieh, T. ‐., & WU, J. M. (2000) · PubMed · Cited by 76
Deletion of 11q23 and Cyclin D1 Overexpression Are Frequent Aberrations in Parathyroid Adenomas
Hemmer, S., Wasenius, V.-M., Haglund, C. H., Zhu, Y., Knuutila, S., Franssila, K., & Joensuu, H. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64086-2 · Cited by 76
Resveratrol-mediated sensitisation to TRAIL-induced apoptosis depends on death receptor and mitochondrial signalling
Fulda, S., & Debatin, K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.020 · Cited by 74
Intracellular Mechanisms of TRAIL and Its Role in Cancer Therapy
Srivastava, R. K. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2001.0265 · Cited by 69
BENZO[A]PYRENE-INDUCED ORAL CARCINOGENESIS AND CHEMOPREVENTION: STUDIES IN BIOENGINEERED HUMAN TISSUE
Walle, T., Walle, U. K., Sedmera, D., & Klausner, M. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007948 · Cited by 64
Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress
Bruder, J. L., Hsieh, T., Lerea, K. M., Olson, S. C., & WU, J. M. (2001) · BMC Cell Biology · doi:10.1186/1471-2121-2-1 · Cited by 61
Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts
Naesens, L. M. J., Bonnafous, P., Agut, H., & Clercq, E. D. (2006) · Journal of Clinical Virology · doi:10.1016/s1386-6532(06)70015-4 · Cited by 57
Protective Effect of Resveratrol, a Polyphenolic Phytoalexin on Glycerol-Induced Acute Renal Failure in Rat Kidney
Chander, V., & Chopra, K. (2006) · Renal Failure · doi:10.1080/08860220500531112 · Cited by 42
Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells
Zhang, W., Fei, Z., Zhen, H., Zhang, J., & Zhang, X. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9226-x · Cited by 42
Reactive Oxygen Species Drives Myocardial Angiogenesis?
Maulik, N. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2161 · Cited by 39
Modulation of TRAIL Signaling for Cancer Therapy
Fulda, S., & Debatin, K. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)67015-4 · Cited by 34
Protective effect of resveratrol against oxidative damage of UVA irradiated HaCaT cells.
Chen, M., Li, J., Xiao, W.-R., et al. (2006) · PubMed · Cited by 28
Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells.
Duraj, J., Bodo, J., Sulíková, M., Rauko, P., & Sedlák, J. (2006) · PubMed · Cited by 22
Apoptosis and cancer chemotherapy
Hickman, J. A., Potten, C. S., Merritt, A. J., et al. (1995) · Springer eBooks · doi:10.1007/978-94-011-0553-8_14 · Cited by 17

The molecular targets of resveratrol
Kulkarni, S. S., & Cantó, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.005 · Cited by 477
“in a number of cell lines following Rsv treatment (see [95] and [98]), also supporting the Rsv chemopreventive activity.”
Background
Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives
Kundu, J. K., & Surh, Y.-J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.057 · Cited by 473
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms
Athar, M., Back, J. H., Kopelovich, L., Bickers, D. R., & Kim, A. L. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.01.018 · Cited by 462
Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases—Safety, Pharmacokinetics, and Pharmacodynamics
Howells, L. M., Berry, D. P., Elliott, P. J., Jacobson, E. W., Hoffmann, E., Hegarty, B., Brown, K., Steward, W. P., & Gescher, A. J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0148 · Cited by 444
Bioavailability of phytochemicals and its enhancement by drug delivery systems
Aqil, F., Munagala, R., Jeyabalan, J., & Vadhanam, M. V. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.032 · Cited by 398

See all 342

Authors: Shankar, S.
Venue: Frontiers in Bioscience
Publisher: IMR Press
Published: 2007
Volume: 12
Issue: 12
Pages: 4839
ISSN: 1093-4715 (ISSN-L)
1093-9946
DOI: 10.2741/2432
OpenAlex: W1966011016
Cited by: 342
References: 178
FWCI: 12.02
Type: journal article
Language: en
Open access: bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources